5型腺相关病毒经PDGFRα感染与系统性硬化症间质性肺病相关,并产生被患者体内激动性免疫球蛋白识别的复合肽与表位
研究探讨5型腺相关病毒(AAV5)与血小板衍生生长因子受体α(PDGFRα)的相互作用及其在系统性硬化症(SSc)发病中的作用。结果显示,SSc合并间质性肺病患者支气管肺泡灌洗液中AAV5检出率(41/66,62.1%)高于对照(17/66,25.75%)(P<0.001),且AAV5衣壳与PDGFRα形成复合表位,可被SSc患者血清中的激动性抗PDGFRα抗体识别。
要点
- SSc合并间质性肺病患者支气管肺泡灌洗液AAV5检出率为62.1%(41/66),高于对照的25.75%(17/66)(P<0.001)。
- SSc肺组织中AAV5定位于II型肺泡上皮细胞和间质细胞。
- AAV5衣壳与PDGFRα形成空间相邻的复合表位,可被SSc患者激动性抗PDGFRα抗体及总IgG识别。
核心结论
- 这些数据将AAV5与SSc中对自身抗原的免疫反应联系起来,为SSc发病机制提供了新元素。
研究设计与样本
- 研究采用硅烷分子对接、表面等离子共振(SPR)和PDGFRα基因座基因组编辑分析人PDGFRα单体与AAV5衣壳的结合。
- 通过原位杂交、免疫组化、共聚焦显微镜和支气管肺泡灌洗液分子分析检测SSc肺组织中的AAV5。
- 利用SSc单克隆抗PDGFRα抗体及从SSc患者血清中免疫亲和纯化的抗PDGFRα抗体,通过SPR评估对AAV5和PDGFRα的免疫反应。
主要发现
- AAV5在66例SSc合并间质性肺病患者中的41例(62.1%)支气管肺泡灌洗液中检出,在66例对照中的17例(25.75%)中检出(P<0.001)。
- 在SSc肺组织中,AAV5定位于II型肺泡上皮细胞和间质细胞。
- 识别并表征了由AAV5衣壳与PDGFRα空间相邻表位形成的分子复合物。
- 硅烷分子对接分析和与激动性抗PDGFRα抗体的结合鉴定出源自PDGFRα和AAV5的空间相邻表位,这些表位与SSc激动性抗PDGFRα抗体相互作用。
- 这些肽段还能结合从SSc患者(而非健康对照)中分离的总IgG。
关键数值与推荐
- SSc合并间质性肺病患者支气管肺泡灌洗液AAV5检出率为62.1%(41/66),对照组为25.75%(17/66),P<0.001。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The etiopathogenesis of systemic sclerosis (SSc) is unknown. Platelet-derived growth factor receptors (PDGFRs) are overexpressed in patients with SSc. Because PDGFRα is targeted by the adeno-associated virus type 5 (AAV5), we investigated whether AAV5 forms a complex with PDGFRα exposing epitopes that may induce the immune responses to the virus-PDGFRα complex. METHODS: The binding of monomeric human PDGFRα to the AAV5 capsid was analyzed by in silico molecular docking, surface plasmon resonance (SPR), and genome editing of the PDGFRα locus. AAV5 was detected in SSc lungs by in situ hybridization, immunohistochemistry, confocal microscopy, and molecular analysis of bronchoalveolar lavage (BAL) fluid. Immune responses to AAV5 and PDGFRα were evaluated by SPR using SSc monoclonal anti-PDGFRα antibodies and immunoaffinity-purified anti-PDGFRα antibodies from sera of patients with SSc. RESULTS: AAV5 was detected in the BAL fluid of 41 of 66 patients with SSc with interstitial lung disease (62.1%) and in 17 of 66 controls (25.75%) (P < 0.001). In SSc lungs, AAV5 localized in type II pneumocytes and in interstitial cells. A molecular complex formed of spatially contiguous epitopes of the AAV5 capsid and of PDGFRα was identified and characterized. In silico molecular docking analysis and binding to the agonistic anti-PDGFRα antibodies identified spatially contiguous epitopes derived from PDGFRα and AAV5 that interacted with SSc agonistic antibodies to PDGFRα. These peptides were also able to bind total IgG isolated from patients with SSc, not from healthy controls. CONCLUSION: These data link AVV5 with the immune reactivity to endogenous antigens in SSc and provide a novel element in the pathogenesis of SSc.
引用
- Moroncini G, Svegliati S, Grieco A, et al. Adeno-Associated Virus Type 5 Infection via PDGFRα Is Associated With Interstitial Lung Disease in Systemic Sclerosis and Generates Composite Peptides and Epitopes Recognized by the Agonistic Immunoglobulins Present in Patients With Systemic Sclerosis. Arthritis Rheumatol. 2024. PMID: 37975161. doi:10.1002/art.42746
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。